Scholars Central

Conference abstract

Bioavailability and Bioequivalence: Pharmacokinetic principles

Authors: Abdus Samad

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

B iological products or medicines are therapeutic agents which are produced using a living system or organism. Access to these life-saving biological products is limited because of their expensive costs. Patents of the early biological products will be soon expired in the next few years. Th is allows other biopharmaceutical/biotech companies to manufacture the generic versions of the biological products, which are referred to the follow-on biological products by the United States Food and Drug Administration (FDA) or biosimilar medicinal products by the European Medicine Agency (EMA) of the European Union (EU). Competition of cost-eff ective follow- on biological products with equivalent effi cacy and safety can cut down the costs and hence increase patients? access to the much needed biological pharmaceuticals. Unlike the conventional pharmaceuticals of small molecular, the complexity and heterogeneity of the molecular structure, complicated manufacturing process, diff erent analytical methods, and possibility of severe immunogenecity reactions make evaluation of equivalence (similarity) between the biosimilar products and their corresponding innovator product a great challenge for both scientifi c community and regulatory agencies. In this paper, we will provide an overview of the current regulatory requirements for approval of biosimilar products. A review of current criteria for evaluation of bioequivalence for the traditional chemical generic products is provided. In addition, statistical considerations including design, criteria, fundamental biosimilar assumption and statistical methods are proposed. Th e possibility of using genomic data in evaluation of biosimilar products is also explored

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Bioequivalence & Bioavailability.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioequivalence & Bioavailability
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Abdus Samad”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels